You are here:
Publication details
CD19 promotor hypermethylation results in CD19 antigen-negative relapse to CAR-T cells.
| Authors | |
|---|---|
| Year of publication | 2021 |
| Type | Requested lectures |
| MU Faculty or unit | |
| Citation |
| Authors | |
|---|---|
| Year of publication | 2021 |
| Type | Requested lectures |
| MU Faculty or unit | |
| Citation |